歌礼制药有限公司（股票代码：01672，股票名称：歌礼制药-B）于2026年10月27日发布翌日披露报表，公告当日回购普通股股份100,000股。该回购数量约占公司已发行股本的0.0095%。本次回购每股价格最高为5.445港元、最低为5.355港元，合计支出540,570港元（约54.06万港元）。
本次回购后，公司已发行股本维持在1,052,202,859股，库藏股数为5,784,210股，总股本为1,057,987,069股。根据公司于2026年6月29日通过的购回授权，公司可回购股份总数为106,137,084股，累计购回数量为5,095,000股，占购回授权通过当日公司已发行股本的0.48%。
公司声明已遵守相关上市规则及当地适用法律法规，公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.